Certified by Founder Lodge
Avidity Partners
United States - ND
INVESTOR
1 Disclosed Funding Rounds $50,000,000
7 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Avidity Private Fund I is a buyout fund managed by Avidity Partners. The fund is located in Dallas, Texas.
| Company | Date | Round | Raised |
|---|---|---|---|
 Quanta Therapeutics |
May, 23 ,2023 | Series D | $50,000,000 |
 Octave |
June, 16 ,2023 | Series C | $52,000,000 |
 MBrace Therapeutics |
November, 15 ,2023 | Series B | $85,000,000 |
 Calyxo, Inc. |
December, 13 ,2023 | Series D | $50,000,000 |
 858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
 Sirona Medical |
November, 27 ,2024 | Series C | $42,000,000 |
 Affinia Therapeutics |
October, 10 ,2025 | Series C | $40,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
